PoursuitAllait: Factors Associated With Continuation of Exclusive Breastfeeding Until the Post-natal Visit

• Sponsor: Université de Reims Champagne-Ardenne (Other)
• Overall Status: Not yet recruiting
• CT.gov ID: NCT05650684
• Collaborator: (none)
• Enrollment: 100
• Anticipated Duration (Months): 5.9

Study Details

Study Description

Brief Summary

Breastfeeding promotes the health of mother and her child, and remains the reference in terms of infant nutrition. World Health Organization recommends exclusive breastfeeding for the first six months. This recommended duration is not respected in France with a median duration of breastfeeding in France at 3 months.

Condition or Disease	Intervention/Treatment	Phase
Breastfeeding	Other: data collection

Detailed Description

The aim is to study factors associated with continuation of exclusive breastfeeding until the post-natal visit.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 100 participants
• Observational Model: Case-Only
• Time Perspective: Cross-Sectional
• Official Title: Factors Associated With Continuation of Exclusive Breastfeeding Until the Post-natal Visit
• Anticipated Study Start Date: Jan 1, 2023
• Anticipated Primary Completion Date: Apr 1, 2023
• Anticipated Study Completion Date: Jul 1, 2023

Arms and Interventions

Arm	Intervention/Treatment
"exclusive breastfeeding" group Women initiating exclusive breastfeeding after birth	Other: data collection; continuation of exclusive breastfeeding until the post-natal visit (6 to 8 weeks after birth)

Outcome Measures

Primary Outcome Measures

1. breastfeeding [Day 0]

   number of women practicing or not exclusive breastfeeding until postnatal consultation (6 to 8 weeks after birth)

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: Female

Inclusion Criteria:

• primiparous and multiparous women

• women who have initiate breastfeeding

• women aged 18 and more

• agreeing to participate in the study

Exclusion Criteria:

• women whose newborn has been in intensive care unit

• women with a multiple pregnancy

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Université de Reims Champagne-Ardenne

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Université de Reims Champagne-Ardenne
• ClinicalTrials.gov Identifier: NCT05650684
• Other Study ID Numbers: 2022_RIPH_013_Poursuit-Allait
• First Posted: Dec 14, 2022
• Last Update Posted: Dec 16, 2022
• Last Verified: Dec 1, 2022

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Université de Reims Champagne-Ardenne: exclusive breastfeeding; postnatal visit; factors associated

Study Results

No Results Posted as of Dec 16, 2022